Transgenic antigen-specific, allogeneic HLA-A*0201-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificity

被引：0
|
作者：
Schirmer, D. [1 ,2 ]
Busch, D. H. [3 ]
Uckert, W. [4 ]
Krackhardt, A. [5 ]
Klar, R. [5 ]
Burdach, S. [1 ,2 ,5 ]
Richter, G. [1 ,2 ]
机构：
[1] Tech Univ Munich, Klinikum Rechts Isar, Childrens Canc Res Ctr, Munich, Germany
[2] Dept Pediat, Munich, Germany
[3] Tech Univ Munich, Klinikum Rechts Isar, Inst Med Microbiol Immunol & Hyg, Munich, Germany
[4] Max Delbruck Ctr Mol Med, Berlin, Germany
[5] Tech Univ Munich, Klinikum Rechts Isar, Med Dept Hematol & Oncol 3, Munich, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
0179
引用
收藏
页码：125 / 125
页数：1
相关论文
共 50 条
  • [21] Identification of human leucocyte antigen (HLA)-A*0201-restricted cytotoxic T lymphocyte epitopes derived from HLA-DOβ as a novel target for multiple myeloma
    Kang, Yoon Joong
    Zeng, Wanyong
    Song, Weihua
    Reinhold, Bruce
    Choi, Jaewon
    Brusic, Vladimir
    Yamashita, Takuto
    Munshi, Aditya
    Li, Cheng
    Minvielle, Stephane
    Anderson, Kenneth C.
    Munshi, Nikhil
    Reinherz, Ellis L.
    Sasada, Tetsuro
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (03) : 343 - 351
  • [22] Identification of Novel HLA-Restricted PRAME Peptides to Facilitate "Off-the-shelf" Tumor-Associated Antigen-specific T-cells
    Stanojevic, M.
    O'Brien, S.
    Geiger, A.
    Ulrey, R. K.
    Cruz, C. Y.
    Hanley, P.
    Keller, M.
    Bollard, C.
    CYTOTHERAPY, 2020, 22 (05) : S136 - S137
  • [23] In vitro expansion of antigen-specific cytotoxic T lymphocytes by HLA-A*0201 transfected K562 for monitoring of T-cell responses
    Yuan, J
    Gallardo, HF
    Rasalan, T
    Ranganathan, R
    Wang, J
    Zhang, Y
    Stan, R
    Young, JW
    Houghton, AN
    Wolchok, JD
    JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) : 635 - 635
  • [24] A minority of tumor associated antigen specific T cells restricted to self-HLA alleles is of sufficient avidity to recognize overexpressed endogenously processed antigen
    Roex, Marthe C. J.
    Hageman, Lois
    van Egmond, Esther
    Veld, Sabrina A. J.
    Hoogstraten, Conny
    Germeroth, Lothar
    Falkenburg, J. H. Frederik
    Jedema, Inge
    BONE MARROW TRANSPLANTATION, 2018, 53 : 43 - 44
  • [25] Identification of HLA-A*0201-restricted T cell epitopes derived from the novel overexpressed tumor antigen calcium-activated chloride channel 2
    Konopitzky, R
    König, U
    Meyer, RG
    Sommergruber, W
    Wölfel, T
    Schweighoffer, T
    JOURNAL OF IMMUNOLOGY, 2002, 169 (01): : 540 - 547
  • [26] Characterization of HLA-A*0201 restricted cytotoxic CD8+T cells directed against ewing tumor specific antigens
    Pirson, S.
    Thiel, U.
    Bernhard, H.
    Richter, G. H. S.
    Burdach, S.
    KLINISCHE PADIATRIE, 2009, 221 (03): : 204 - 204
  • [27] In vitro priming with adenovirus/gp100 antigen-transduced dendritic cells reveals the epitope specificity of HLA-A*0201-restricted CD8+ T cells in patients with melanoma
    Linette, GP
    Shankara, S
    Longerich, S
    Yang, SX
    Doll, R
    Nicolette, C
    Preffer, FI
    Roberts, BL
    Haluska, FG
    JOURNAL OF IMMUNOLOGY, 2000, 164 (06): : 3402 - 3412
  • [28] Rebuilding HLA class-II restricted, myeloma associated minor H antigen specificity in recall antigen-specific T cells by T cell receptor transfer
    Spaapen, R.
    van den Oudenalder, K.
    Ivanov, R.
    Bloem, A.
    Lokhorst, H. M.
    Mutis, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 184 - 184
  • [29] Quantum dot/pMHC multimers vs. phycoerythrin/pMHC tetramers for identification of HLA-A*0201-restricted pHBV core antigen18-27-specific T cells
    Zhu, Jianmeng
    Huang, Yong
    Su, Jing
    He, Jian
    Yu, Yating
    Zhao, Yongxiang
    Lu, Xiaoling
    MOLECULAR MEDICINE REPORTS, 2017, 16 (06) : 8605 - 8612
  • [30] Identification of a novel HLA-A* 0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor α2 chain (vol 8, pg 2851, 2002)
    Okano, F
    Storkus, WJ
    Chambers, WH
    Pollack, IF
    Okada, H
    CLINICAL CANCER RESEARCH, 2006, 12 (11) : 3552 - 3552
12345